Clinical Study of OR for Second-line Treatment of Refractory MZL
Clinical Study of OR for Second-line Treatment of Refractory MZL
Recruiting · NCT06134284 · Registry updated 2024-06-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of OR for Second-line Treatment of Refractory MZL | B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 4 | 2024-06-11 | NCT06134284 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lixia Sheng | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| 86-574-87085596 | Ningbo | China | 1 |
| The first affiliated hospital of Ningbo university | Ningbo | China | 35 |
| The Second Affiliated Hospital of Zhejiang University, Ningbo First Hospital | Hangzhou | China | 2 |